Recent advances in bionanomaterials for liver cancer diagnosis and treatment

被引：30
作者：
Chowdhury, Mohammed Mehadi Hassan [1 ,2 ]
Salazar, Christiancel Joseph J. [3 ]
Nurunnabi, Md [3 ,4 ,5 ,6 ]
机构：
[1] Deakin Univ, Fac Hlth, Sch Med, 75 Pigdons Rd, Waurnponds, Vic 3216, Australia
[2] Noakhali Sci & Technol Univ, Dept Microbiol, Noakhali 3814, Bangladesh
[3] Univ Texas El Paso, Environm Sci & Engn, El Paso, TX 79968 USA
[4] Univ Texas El Paso, Biomed Engn, El Paso, TX 79968 USA
[5] Univ Texas El Paso, Sch Pharm, Dept Pharmaceut Sci, El Paso, TX 79902 USA
[6] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA
来源：
BIOMATERIALS SCIENCE | 2021年 / 9卷 / 14期
关键词：
MESOPOROUS SILICA NANOPARTICLES; IRON-OXIDE NANOPARTICLES; HEPATOCELLULAR-CARCINOMA; CO-DELIVERY; IN-VITRO; ARSENIC TRIOXIDE; PHOTOTHERMAL THERAPY; GOLD NANOPARTICLES; TARGETED DELIVERY; DRUG-DELIVERY;
D O I：
10.1039/d1bm00167a
中图分类号：
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号：
0805 ; 080501 ; 080502 ;
摘要：
According to the World Health Organization, liver cancer is the fourth leading cause of cancer associated with death worldwide. It demands effective treatment and diagnostic strategies to hinder its recurrence, complexities, aggressive metastasis and late diagnosis. With recent progress in nanotechnology, several nanoparticle-based diagnostic and therapeutic modalities have entered into clinical trials. With further developments in nanoparticle mediated liver cancer diagnosis and treatment, the approach holds promise for improved clinical liver cancer management. In this review, we discuss the key advances in nanoparticles that have potential for liver cancer diagnosis and treatment. We also discuss the potential of nanoparticles to overcome the limitations of existing therapeutic modalities.
引用
收藏
页码：4821 / 4842
页数：22
相关论文
共 231 条
  • [101] Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma
    Koh, Iemasa
    Hinoi, Takao
    Sentani, Kazuhiro
    Hirata, Eiji
    Nosaka, Suguru
    Niitsu, Hiroaki
    Miguchi, Masashi
    Adachi, Tomohiro
    Yasui, Wataru
    Ohdan, Hideki
    Kudo, Yoshiki
    [J]. CANCER MEDICINE, 2016, 5 (07): : 1546 - 1555
  • [102] 3D Bioprinting of Vascularized, Heterogeneous Cell-Laden Tissue Constructs
    Kolesky, David B.
    Truby, Ryan L.
    Gladman, A. Sydney
    Busbee, Travis A.
    Homan, Kimberly A.
    Lewis, Jennifer A.
    [J]. ADVANCED MATERIALS, 2014, 26 (19) : 3124 - 3130
  • [103] Hepatocellular carcinoma treatment: hurdles, advances and prospects
    Kumari, Ratna
    Sahu, Manoj Kumar
    Tripathy, Anindita
    Uthansingh, Kanishka
    Behera, Manas
    [J]. HEPATIC ONCOLOGY, 2018, 5 (02)
  • [104] Le Grazie M, 2017, WORLD J HEPATOL, V9, P907, DOI 10.4254/wjh.v9.i21.907
  • [105] Non-infective occupational risk factors for hepatocellular carcinoma: A review
    Ledda, Caterina
    Loreto, Carla
    Zammit, Christian
    Marconi, Andrea
    Fago, Lucrezia
    Matera, Serena
    Costanzo, Valentina
    Sanza, Giovanni Fuccio
    Palmucci, Stefano
    Ferrante, Margherita
    Costa, Chiara
    Fenga, Concettina
    Biondi, Antonio
    Pomara, Cristoforo
    Rapisarda, Venerando
    [J]. MOLECULAR MEDICINE REPORTS, 2017, 15 (02) : 511 - 533
  • [106] Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study
    Lee, Seunghyun
    Kim, Jung Hoon
    Moon, Hyungwon
    Lee, Hak Jong
    Han, Joon Koo
    [J]. PLOS ONE, 2020, 15 (12):
  • [107] MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
    Li, Dong
    Liu, Xingguang
    Lin, Li
    Hou, Jin
    Li, Nan
    Wang, Chunmei
    Wang, Pin
    Zhang, Qian
    Zhang, Peng
    Zhou, Weiping
    Wang, Zhengxin
    Ding, Guoshan
    Zhuang, Shi-Mei
    Zheng, Limin
    Tao, Wenzhao
    Cao, Xuetao
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (42) : 36677 - 36685
  • [108] Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice
    Li, Guangfu
    Liu, Dai
    Kimchi, Eric T.
    Kaifi, Jussuf T.
    Qi, Xiaoqiang
    Manjunath, Yariswamy
    Liu, Xinjian
    Deering, Tye
    Avella, Diego M.
    Fox, Todd
    Rockey, Don C.
    Schell, Todd D.
    Kester, Mark
    Staveley-O'Carroll, Kevin F.
    [J]. GASTROENTEROLOGY, 2018, 154 (04) : 1024 - +
  • [109] Iron oxide nanoparticles for targeted imaging of liver tumors with ultralow hepatotoxicity
    Li, Juanjuan
    Cha, Ruitao
    Zhang, Yulong
    Guo, Hongbo
    Long, Keying
    Gao, Pangye
    Wang, Xiaohui
    Zhou, Fengshan
    Jiang, Xingyu
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2018, 6 (40) : 6413 - 6423
  • [110] A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy
    Li, Min
    Su, Yujie
    Zhang, Fangrong
    Chen, Kerong
    Xu, Xiangting
    Xu, Lin
    Zhou, Jianping
    Wang, Wei
    [J]. ACTA BIOMATERIALIA, 2018, 75 : 413 - 426
6789101112131415